London’s Sava raises €32.08 million and partners with Ascensia to bring its glucose microsensor to Europe
Sava Technologies, a London-based HealthTech company developing a wearable biosensor platform that detects molecules just beneath the skin, today announced a $36 million Series B round to fund manufacturing scale-up and commercial readiness. The round was led by Ascensia, with participation from ins
<p>Sava Technologies, a London-based HealthTech company developing a wearable biosensor platform that detects molecules just beneath the skin, today announced a $36 million Series B round to fund manufacturing scale-up and commercial readiness. The round was led by Ascensia, with participation from ins</p>